Previous Page  5 / 25 Next Page
Information
Show Menu
Previous Page 5 / 25 Next Page
Page Background

Gastro Education 2018

Journal of Clinical Gastroenterology and Hepatology

ISSN: 2575-7733

Page 44

September 06-07, 2018

London, UK

14

th

International Conference on

Gastro Education

M

icroRNAs are non-coding RNA molecules, inhibiting or

abrogating the translation process of their mRNA target.

Let-7 is the prototypical microRNA family. Thirteeen precursor

transcriptsareprocessedandgenerate tenmature let-7members.

Nevertheless, mature and precursor let-7molecules are produced

in distinct rates throughout carcinogenesis process. This

differentiated expression may contribute in the genetic regulation

of many cancers, including gastrointestinal ones. The mission

of let-7 in the gastrointestinal tract and in both liver/pancreas is

to promote differentiation and to depress stemness. Although

scarce reports imply its oncogenecity, let-7 is widely considered a

tumor-suppressor gene, as it downregulates every single hallmark

of cancer. Let-7 targets a plentitude of crucial oncogenes (K-ras,

c-myc) and in a lesser degree, tumor-suppressor genes or tumor-

suppressive pathways (p53, Wnt/APC). K-ras oncogene, the most

prevalent oncogenic driver mutation in colorectal and pancreatic

cancer, is the dominant target of let-7. The interplay between let-

7 and its effectors is complex, as approximately all let-7 targets

behave as its reciprocal regulators, mainly negative. Moreover,

let-7 is autoregulated (positively or negatively), and it depends its

effect either on other miRNAs or on dietary compounds. Despite

the well-documented pathogenetic, prognostic, predictive,

diagnostic and therapeutic role of let-7 in colorectal cancer,

recent research has documented its crucial role in the epigenetic

regulation of other gastrointestinal cancers as well, as those of

pancreas, liver, stomach and esophagus. The aim of this e-poster

presentation is to outline the current data regarding the role of

let-7 in the tumor-suppressive circuits of several gastrointestinal

tumorigenesis processes.

Biography

Nikolaos G Margetis graduated from University of Patras (Greece) in 1995.

He has specialized in Gastroenterology since 2005 and Specialist in EUS

since 2006. Since July 2017 he holds a PhD Degree from Medical School

of National and Kapodistrain University of Athens, Greece. He has been a

Consultant in three Great Hospitals of Athens. He was a Member of SOS

DOCTORS of Athens for six years. Since 2013 he is a Member of Athens

University (belongs to the Molecular Carcinogenesis Group and teaches the

undergraduate and postgraduate students of the Medical and the Nursing

Schools). He has 10 publications in reputed international medical journals,

30 publications in greek medical journals and has contributed in 2 Greek

Medical textbooks’ writing. He is the Editorial Board Member in 4 and Re-

viewer in 3 international medical journals with authority. He was awarded for

his work in two congresses and in many hands-on courses. He organized

the 1st Greek Congress “Georgios Papanicolaou-The prevention of cancer”.

nmargetis@yahoo.gr

The central role of let-7 microRNA in the genetic regulation of

various gastrointestinal cancers

Nikolaos G Margetis

National and Kapodistrian University of Athens, Greece

Nikolaos G Margetis, J Clin Gastroenterol Hepatol 2018, Volume 2

DOI: 10.21767/2575-7733-C2-006